Type 2 Diabetes Screening and Treatment Guideline

Download Type 2 Diabetes Screening and Treatment Guideline PDF prepared by Kaiser Foundation Health Plan of Washington. It is now recommended that diabetes screening for patients with overweight/obesity start at age 35, to be in alignment with new 2021 U.S.

Type 2 Diabetes Screening and Treatment Guideline PDF

PDF NameType 2 Diabetes Screening and Treatment Guideline
Published/Updated On
Category
RegionGlobal
No. of Pages24
PDF Size0.57 MB
LanguageEnglish
Source(s) / Creditswa.kaiserpermanente.org

Download PDF of Type 2 Diabetes Screening and Treatment Guideline from wa.kaiserpermanente.org using the direct download link given at the bottom of this article.

Type 2 Diabetes Screening and Treatment Guideline PDF - Overview

Type 2 Diabetes Screening and Treatment Guideline – Type 2 diabetes is an impairment in the way the body regulates and uses sugar (glucose) as a fuel. This long-term (chronic) condition results in too much sugar circulating in the bloodstream. Eventually, high blood sugar levels can lead to disorders of the circulatory, nervous and immune systems.

Type 2 Diabetes Screening and Treatment Guideline

Contents of Type 2 Diabetes Screening and Treatment Guideline

  • Interim Update September 2021
  • Changes as of March 2021
  • Prevention
  • Screening and Tests
  • Diagnosis
  • Treatment
  • Risk-reduction goals
  • Lifestyle modifications and non-pharmacologic options
  • Bariatric surgery
  • Pharmacologic options for glucose control
  • Type 2 diabetes treatment workflow for Primary Care
  • Type 2 diabetes treatment: when to consider glargine or U-500 insulin
  • Additional pharmacologic options to consider in consultation with Diabetes Team
  • Pharmacologic options that are not recommended
  • Referral to Nursing or Clinical Pharmacy
  • Follow-up and Monitoring
  • Self blood glucose monitoring
  • Periodic monitoring of conditions and complications
  • Medication monitoring
  • Recommended immunizations
  • Comorbidities
  • Evidence Summary
  • References
  • Guideline Development Process and Team
  • Last guideline approval: March 2021

Diagnosis

TestResultInterpretation
HBA1c6.5% or HigherDiabetes
5.7-6.4%Impaired Glucose Tolerance
Lower than 5.7%Normal
Random Plasma Glucose200 Mg/Dl or HigherDiabetes
140-199 Mg/DlImpaired Glucose Tolerance
Lower than 140 Mg/DlNormal
Fasting Plasma Glucose126 Mg/Dl or HigherDiabetes
100-125 Mg/DlImpaired Glucose Tolerance
Lower than 100 Mg/DlNormal
Download Type 2 Diabetes Screening and Treatment Guideline PDF from wa.kaiserpermanente.org using the direct download link given below.

Type 2 Diabetes Screening and Treatment Guideline PDF Download Link

Download PDF

RELATED PDF FILES

LATEST UPLOADED PDF FILES

Leave a Reply

Your email address will not be published.